Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Selby

Showing results (241-250 of 264) with videos related to

Pageof 27
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
CSB-independent, XPC-dependent transcription-coupled repair in <i>Drosophila</i>Nazli Deger, Xuemei Cao, Christopher P Selby, et al.
Blood|August 1, 1996
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation StudyM E Hill, K A MacLennan, D C Cunningham, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2015
FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UKE McCloskey, J A Kanis, H Johansson, et al.
Gene Therapy|February 29, 2008
Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumorsJ Qiao, H Wang, T Kottke, et al.
Nature Communications|July 15, 2016
SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeedingHagoon Jang, Gha Young Lee, Christopher P Selby, et al.
International Journal of Cancer|August 29, 2013
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascitesV A Jennings, E J Ilett, K J Scott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphomaS Rao, D Watkins, D Cunningham, et al.
Gene Therapy|April 11, 2008
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanomaF Errington, C L White, K R Twigger, et al.
Gene Therapy|December 16, 2011
Measles virus causes immunogenic cell death in human melanomaO G Donnelly, F Errington-Mais, L Steele, et al.
British Journal of Cancer|March 3, 2011
Strengthening clinical cancer research in the United KingdomM Stead, D Cameron, N Lester, et al.
Pageof 27

Showing results (241-250 of 264) with videos related to

Sort By:
Pageof 27
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
CSB-independent, XPC-dependent transcription-coupled repair in <i>Drosophila</i>Nazli Deger, Xuemei Cao, Christopher P Selby, et al.
Blood|August 1, 1996
Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation StudyM E Hill, K A MacLennan, D C Cunningham, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 17, 2015
FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UKE McCloskey, J A Kanis, H Johansson, et al.
Gene Therapy|February 29, 2008
Loading of oncolytic vesicular stomatitis virus onto antigen-specific T cells enhances the efficacy of adoptive T-cell therapy of tumorsJ Qiao, H Wang, T Kottke, et al.
Nature Communications|July 15, 2016
SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeedingHagoon Jang, Gha Young Lee, Christopher P Selby, et al.
International Journal of Cancer|August 29, 2013
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascitesV A Jennings, E J Ilett, K J Scott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphomaS Rao, D Watkins, D Cunningham, et al.
Gene Therapy|April 11, 2008
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanomaF Errington, C L White, K R Twigger, et al.
Gene Therapy|December 16, 2011
Measles virus causes immunogenic cell death in human melanomaO G Donnelly, F Errington-Mais, L Steele, et al.
British Journal of Cancer|March 3, 2011
Strengthening clinical cancer research in the United KingdomM Stead, D Cameron, N Lester, et al.
Pageof 27